Byers Capital

Byers Capital is a family office established in 2021 and located in San Francisco, California. The firm specializes in investing in startups during their Series A and B funding rounds, primarily targeting the technology and biotechnology sectors. Byers Capital aims to support emerging companies that demonstrate innovative potential and growth prospects within these industries.

Blake Byers Ph.D

Founder

7 past transactions

PinkDx

Series A in 2024
PinkDx is a biotechnology company specializing in women's health. It develops molecular tests to improve diagnostic outcomes for women with vague gynecological cancer symptoms, offering alternatives to invasive procedures. This enables more comfortable and efficient resolution of health concerns, providing timely and positive impacts on patients' lives.

Waltz Health

Series A in 2022
Waltz Health is a company focused on innovating the pharmaceutical supply chain by developing technology-driven solutions for pricing, distribution, and prescription of medications. It collaborates with various partners, including consumers, payers, and pharmacies, to create smarter ways to manage prescription care. The company utilizes AI-driven marketplaces to reduce costs and offers consumer tools that enhance decision-making regarding healthcare. These tools provide users with better pricing, comprehensive information, and resources aimed at lowering expenses, empowering consumers, and enabling payers to effectively manage their pharmacy benefits. Through these efforts, Waltz Health strives to improve the overall experience and affordability of prescription medications.

Ostro

Series B in 2022
Ostro is a health platform based in Miami, Florida, founded in 2019, that specializes in personalized engagement solutions for the life sciences sector. The company focuses on creating informative connections between medicine producers and consumers, enhancing healthcare experiences for both patients and healthcare professionals. Ostro's platform streamlines the patient journey, offering services such as virtual consultations, logistics, regulatory compliance, and integrated payment solutions. By personalizing healthcare journeys, Ostro aims to boost engagement and improve the overall health outcomes for millions of individuals while delivering value to life sciences brands.

Getlabs

Series A in 2022
Getlabs, Inc. is a digital health company founded in 2018 and based in Santa Monica, California, specializing in at-home diagnostics. The platform enables healthcare organizations to send mobile phlebotomists to patients' homes for the collection of lab tests, vital signs, and advanced diagnostics. By facilitating these at-home appointments, Getlabs enhances patient adherence and addresses gaps in care through its nationwide, same-day service. The company aims to improve access to essential diagnostic services, effectively bridging the divide between virtual and in-person healthcare. With significant backing from major diagnostic laboratories, Getlabs is committed to expanding access to diagnostics for all patients, thereby supporting better health outcomes.

Culdesac

Series A in 2022
Culdesac Inc. is a real estate development company based in San Francisco, California, focused on creating car-free residential neighborhoods in the United States. Established in 2018, the company's first project is in Tempe, Arizona, where it aims to build the first car-free neighborhood from scratch in the country. This innovative approach prioritizes pedestrian accessibility and eco-friendly living by eliminating parking spaces for residents while providing designated areas for visitors. The neighborhood will feature essential services such as grocery stores, coffee shops, coworking spaces, and market halls, allowing residents to engage with their community directly from their doorsteps. Culdesac's vision is to reimagine urban living by putting people before cars, fostering a sustainable and vibrant lifestyle.

Benchling

Series E in 2021
Benchling, Inc. is a cloud-based informatics company that provides a comprehensive platform tailored for life sciences research and development. Its flagship offering allows scientists to design, share, and document experiments through an integrated interface, enhancing collaboration and efficiency. The platform includes Benchling Insights, which enables users to query and visualize structured data, and a Bioregistry system for managing biological entity registrations and inventory such as plasmids and cell strains. Benchling's solutions support a variety of applications, including antibodies, cell therapy, gene therapy, and vaccines, catering to the needs of scientists in biotech, pharmaceutical, academic, and government sectors. Founded in 2012 and headquartered in San Francisco, Benchling aims to streamline the research process from discovery to bioprocessing, facilitating critical R&D decisions with its unified software suite.

Ostro

Series A in 2019
Ostro is a health platform based in Miami, Florida, founded in 2019, that specializes in personalized engagement solutions for the life sciences sector. The company focuses on creating informative connections between medicine producers and consumers, enhancing healthcare experiences for both patients and healthcare professionals. Ostro's platform streamlines the patient journey, offering services such as virtual consultations, logistics, regulatory compliance, and integrated payment solutions. By personalizing healthcare journeys, Ostro aims to boost engagement and improve the overall health outcomes for millions of individuals while delivering value to life sciences brands.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.